BioTech
Biotech and life-sciences VCs — therapeutics, diagnostics, computational biology, drug discovery, synthetic biology, and biomanufacturing. Stage-aware filtering for seed-to-Series C founders.
85
20
Top VCs investing in BioTech
View all VCs →Founders Fund
San Francisco, CA
Khosla Ventures
Menlo Park, CA
SBI Investment
Tokyo, Japan
ANRI
Tokyo, Japan
UTEC
Tokyo, Japan
Lux Capital
New York, NY
Andreessen Horowitz Bio Fund
Menlo Park, CA
OrbiMed
New York, NY
ARCH Venture Partners
Chicago, IL
Polaris Partners
Boston, MA
Atlas Venture
Cambridge, MA
F-Prime Capital
Boston, MA
Prime Movers Lab
Jackson, WY
Fifty Years
San Francisco, CA
DCVC (Data Collective)
San Francisco, CA
GV (Andreessen Bio separate)
Menlo Park, CA
2048 Ventures
New York, NY / Boston, MA
Pillar VC
Boston, MA
Amino Capital
Palo Alto, CA
Elaia
Paris, France
Recent investment signals
Flare Therapeutics raised $85M Series C targeting transcription factors for cancer and disease treatments, led by Third Rock Ventures.
Source: The Week’s 10 Biggest Funding Rounds: AI, Energy And Biotech Lead The WayBeeline Medicines raised $126M Series A extension for precision therapies in autoimmune/inflammatory diseases with backing from Bain, CPP, and BMS.
Source: The Week’s 10 Biggest Funding Rounds: AI, Energy And Biotech Lead The WayCell Function Engineering Logomix raised ¥2.8 billion to accelerate U.S. operations, indicating significant late-stage funding for biotech expansion.
Source: Cell Function Engineering Logomix Raises ¥2.8 Billion to Accelerate U.S. Operations - BRIDGE（ブリッジ）Indapta Therapeutics raised over $50 million in Series A financing to develop G-NK cell therapy for multiple cancer types, with new CEO appointment.
Source: Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer - Business WireModulus Discovery completed a Series A funding round of $7.2M, indicating investor confidence in the company's development stage and business model.
Source: Modulus Discovery Raises US$7.2M in Series A Funding Round - FinSMEsBiotech sector shows significant presence as a secondary trend after AI in terms of large funding rounds.
Source: 【6/18 - 6/26】注目の海外スタートアップの大型資金調達｜SecondWave｜米国株・テックトレンドSwanlaab Innvierte demonstrates thesis interest in agrifood-tech biotech investments as a specialized venture fund.
Source: Swanlaab Innvierte Agrifood-Tech Leads a €2 Million Investment Round in KOA Biotech, accompanied by Fund-F and Faber - capital-riesgo.esSwanlaab Innvierte Agrifood-Tech led a €2 million investment round in KOA Biotech alongside Fund-F and Faber, indicating active funding in agrifood biotech space.
Source: Swanlaab Innvierte Agrifood-Tech Leads a €2 Million Investment Round in KOA Biotech, accompanied by Fund-F and Faber - capital-riesgo.esHeqet Therapeutics is mentioned in Italy's VC roundup, indicating active biotech investment activity in the Italian venture ecosystem.
Source: Italy’s angels&incubators and venture capital weekly roundup. News from AIFI-PwC, Newcleo, Primo Digital, CRIF, Heqet Therapeutics, Boom Imagestudio and more – BeBeez International - BeBeez InternationalQurAlis secured $42M in Series A funding to develop therapies for ALS, indicating investor confidence in the company's approach to neurodegenerative disease treatment.
Source: QurAlis raises $42M in Series A round to develop therapies for ALS - MedCity NewsFrequently asked questions
Which VCs are most active in BioTech?
VCWorld ranks VCs by the volume of BioTech-related investment signals and articles. Top of the list = funds actively publishing theses, blogs, and announcing investments in this sector.
How can I narrow down BioTech VCs further?
This hub shows VCs whose focusSectors includes BioTech. Combine it with region hubs (e.g. /regions/us) or stage hubs (e.g. /stages/seriesA) for a tighter shortlist.
What is an investment signal?
Structured data extracted by AI from each VC's official blog and partner-authored articles. We classify signals into thesis, investment, trend, or opinion, each tagged with a confidence score (0-100%).
Where can I see the latest BioTech trends?
The "Signals" section above and the /trends page surface the most recent BioTech signals from the past 30 days, sorted by recency and confidence.